The cell builders and the business builders
Ready for scale and long-term growth
Horizon Discovery's 2016 annual report tells both sides of their story – Horizon’s approach to gene editing and their ambition to transform the lives of patients with genetic diseases (the cell builders), and how they have built a world-leading life sciences capability serving academic research, drug discovery, drug manufacturing and clinical diagnostics customers (the business builders).
The story clearly shows what Horizon offer these four important customer groups, details how they are positioned for future success, and showcases their newly completed UK headquarters and state-of-the art facilities for cell-based work that compliments their centres of excellence in the USA and Austria.
annual reports / investor communication materials / photography and illustration